Evidence map›Paper›PMID 35327462›Full record

ArticleBiomedicines2022

The Pyrazolo[3,4-

Enrico Rango, Fabio Pastorino, Chiara Brignole, Arianna Mancini, Federica Poggialini, Salvatore Di Maria, Claudio Zamperini, Giulia Iovenitti, Anna Lucia Fallacara, Samantha Sabetta and 7 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment.International journal of molecular sciences · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Enrico RangoDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.ORCID 0000-0001-6509-136X
Fabio PastorinoLaboratory of Experimental Therapies in Oncology, IRCCS Istituto G. Gaslini, 16148 Genoa, Italy.ORCID 0000-0002-8312-808X
Chiara BrignoleLaboratory of Experimental Therapies in Oncology, IRCCS Istituto G. Gaslini, 16148 Genoa, Italy.ORCID 0000-0002-2563-6991
Arianna ManciniDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.
Federica PoggialiniDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.ORCID 0000-0002-8225-4631
Salvatore Di MariaDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.ORCID 0000-0002-1442-1004
Claudio ZamperiniLead Discovery Siena S.r.l., Via Vittorio Alfieri 31, 53019 Castelnuovo Berardenga, Italy.
Giulia IovenittiDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.
Anna Lucia FallacaraDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.
Samantha SabettaDipartimento Scienze Cliniche Applicate e Biotecnologiche, Università dell'Aquila, Via Vetoio, 67100 Coppito, Italy.
Letizia ClementiDipartimento Scienze Cliniche Applicate e Biotecnologiche, Università dell'Aquila, Via Vetoio, 67100 Coppito, Italy.
Massimo ValotiDipartimento Scienze della Vita, Università degli Studi di Siena, Via Aldo Moro 2, 53100 Siena, Italy.ORCID 0000-0002-7240-3576
Silvia SchenoneDipartimento di Farmacia, Università degli Studi di Genova, Viale Benedetto XV 3, 16132 Genoa, Italy.
Adriano AngelucciDipartimento Scienze Cliniche Applicate e Biotecnologiche, Università dell'Aquila, Via Vetoio, 67100 Coppito, Italy.ORCID 0000-0002-8755-1889
Mirco PonzoniLaboratory of Experimental Therapies in Oncology, IRCCS Istituto G. Gaslini, 16148 Genoa, Italy.ORCID 0000-0002-6164-4286
Elena DreassiDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.ORCID 0000-0001-8987-940X
Maurizio BottaDipartimento Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, 53100 Siena, Italy.
University of Siena · ITIstituto Giannina Gaslini · ITUniversity of L'Aquila · ITSiena Biotech (Italy) · ITUniversity of Genoa · IT

Funding

Italian Association for Cancer Research IG-2015Italian Association for Cancer Research IG-2019Ministero della Salute RFMSAL5XMRicerca Finalizzata Fondazione Gaslini FGASLINIRF
6 · The paper itself

Abstract

Si306, a pyrazolo[3,4-

Indexed as

anti-GD2 monoclonal antibodyc-Src inhibitorimmunoliposomesliposomesneuroblastoma

Identifiers

PMID35327462
PMCPMC8945814
OpenAlexW4220807792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.